BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27885263)

  • 21. Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.
    Gowda C; Soliman M; Kapadia M; Ding Y; Payne K; Dovat S
    Adv Biol Regul; 2017 Aug; 65():16-25. PubMed ID: 28623166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros.
    Wang H; Ouyang H; Lai L; Petrovic-Dovat L; Stankov K; Bogdanovic G; Dovat S
    J BUON; 2014; 19(1):22-8. PubMed ID: 24659638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.
    Nishii K; Katayama N; Miwa H; Shikami M; Usui E; Masuya M; Araki H; Lorenzo F; Ogawa T; Kyo T; Nasu K; Shiku H; Kita K
    Leukemia; 2002 Jul; 16(7):1285-92. PubMed ID: 12094252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implication of Dynamin-2 (DNM2) Mutations in Adult T-cell Acute Lymphoblastic Leukemia.
    Sobh M; Aref S; Al Agdar M; El Zafrany M; El-Sokkary AMA
    Asian Pac J Cancer Prev; 2023 Apr; 24(4):1257-1264. PubMed ID: 37116148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
    Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
    Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoring Ikaros's wings to solve a leukemia maze.
    Lobry C
    Blood; 2015 Oct; 126(15):1735-6. PubMed ID: 26450952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic regulation of gene expression by Ikaros, HDAC1 and Casein Kinase II in leukemia.
    Song C; Pan X; Ge Z; Gowda C; Ding Y; Li H; Li Z; Yochum G; Muschen M; Li Q; Payne KJ; Dovat S
    Leukemia; 2016 Jun; 30(6):1436-40. PubMed ID: 26639180
    [No Abstract]   [Full Text] [Related]  

  • 28. Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia.
    Witkowski MT; Cimmino L; Hu Y; Trimarchi T; Tagoh H; McKenzie MD; Best SA; Tuohey L; Willson TA; Nutt SL; Busslinger M; Aifantis I; Smyth GK; Dickins RA
    Leukemia; 2015 Jun; 29(6):1301-11. PubMed ID: 25655195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ikaros and leukaemia.
    Olsson L; Johansson B
    Br J Haematol; 2015 May; 169(4):479-91. PubMed ID: 25753742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia.
    Qazi S; Uckun FM
    Haematologica; 2013 Dec; 98(12):e151-2. PubMed ID: 24323986
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis.
    Zhang W; Kuang P; Li H; Wang F; Wang Y
    Ann Hematol; 2017 Feb; 96(2):215-225. PubMed ID: 27815723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large deletions of the 5' region of IKZF1 lead to haploinsufficiency in B-cell precursor acute lymphoblastic leukaemia.
    Morel G; Deau MC; Simand C; Caye-Eude A; Arfeuille C; Ittel A; Miguet L; Mauvieux L; Herbrecht R; Paillard C; Strullu M; Cavé H; Chan S; Kastner P; Heizmann B
    Br J Haematol; 2019 Sep; 186(5):e155-e159. PubMed ID: 31148164
    [No Abstract]   [Full Text] [Related]  

  • 33. [Significance of ikaros family zinc finger 1 deletion in pediatric B-acute lymphoblastic leukemia without reproducible cytogenetic abnormalities].
    Liu X; Zhang L; Zou Y; Chang L; Wei W; Ruan M; Chen Y; Yang W; Chen X; Guo Y; Wang S; Liu T; Zhang J; Liu F; Qi B; An W; Zhu X
    Zhonghua Er Ke Za Zhi; 2016 Feb; 54(2):126-30. PubMed ID: 26875463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
    Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B
    Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
    Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
    J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IKZF1
    Stanulla M; Dagdan E; Zaliova M; Möricke A; Palmi C; Cazzaniga G; Eckert C; Te Kronnie G; Bourquin JP; Bornhauser B; Koehler R; Bartram CR; Ludwig WD; Bleckmann K; Groeneveld-Krentz S; Schewe D; Junk SV; Hinze L; Klein N; Kratz CP; Biondi A; Borkhardt A; Kulozik A; Muckenthaler MU; Basso G; Valsecchi MG; Izraeli S; Petersen BS; Franke A; Dörge P; Steinemann D; Haas OA; Panzer-Grümayer R; Cavé H; Houlston RS; Cario G; Schrappe M; Zimmermann M; ;
    J Clin Oncol; 2018 Apr; 36(12):1240-1249. PubMed ID: 29498923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia.
    Iacobucci I; Iraci N; Messina M; Lonetti A; Chiaretti S; Valli E; Ferrari A; Papayannidis C; Paoloni F; Vitale A; Storlazzi CT; Ottaviani E; Guadagnuolo V; Durante S; Vignetti M; Soverini S; Pane F; Foà R; Baccarani M; Müschen M; Perini G; Martinelli G
    PLoS One; 2012; 7(7):e40934. PubMed ID: 22848414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia.
    Churchman ML; Mullighan CG
    Exp Hematol; 2017 Feb; 46():1-8. PubMed ID: 27865806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss-of-function but not dominant-negative intragenic
    Kobitzsch B; Gökbuget N; Schwartz S; Reinhardt R; Brüggemann M; Viardot A; Wäsch R; Starck M; Thiel E; Hoelzer D; Burmeister T
    Haematologica; 2017 Oct; 102(10):1739-1747. PubMed ID: 28751559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.
    Clappier E; Grardel N; Bakkus M; Rapion J; De Moerloose B; Kastner P; Caye A; Vivent J; Costa V; Ferster A; Lutz P; Mazingue F; Millot F; Plantaz D; Plat G; Plouvier E; Poirée M; Sirvent N; Uyttebroeck A; Yakouben K; Girard S; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Cavé H;
    Leukemia; 2015 Nov; 29(11):2154-61. PubMed ID: 26050650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.